Antipsychotics reduces mortality in patients with neuropsychiatric systemic lupus erythematosus: a retrospective study of psychiatric consultation cases
This study aimed to identify the presence of psychiatric comorbidities as well as investigate the relationship between psychiatric interventions for mental symptoms and mortality in patients with systemic lupus erythematosus (SLE).ObjectiveThis study aimed to identify the presence of psychiatric com...
Saved in:
Published in | Frontiers in psychiatry Vol. 14; p. 1189940 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
31.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study aimed to identify the presence of psychiatric comorbidities as well as investigate the relationship between psychiatric interventions for mental symptoms and mortality in patients with systemic lupus erythematosus (SLE).ObjectiveThis study aimed to identify the presence of psychiatric comorbidities as well as investigate the relationship between psychiatric interventions for mental symptoms and mortality in patients with systemic lupus erythematosus (SLE).We retrospectively evaluated the records of 160 inpatients with SLE who required psychiatric consultation for further therapeutic intervention from 2013 to 2020 in a tertiary general hospital. We collected clinical data, including diagnoses, medications, and mortality rate. We compared clinical characteristics among the diagnosis groups and correlations between variables.MethodWe retrospectively evaluated the records of 160 inpatients with SLE who required psychiatric consultation for further therapeutic intervention from 2013 to 2020 in a tertiary general hospital. We collected clinical data, including diagnoses, medications, and mortality rate. We compared clinical characteristics among the diagnosis groups and correlations between variables.A total of 138 (86.3%) patients met the diagnostic criteria for at least one mental disorder, with the most common being delirium (54.4%). The average Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score significantly differed among the diagnosis groups (p = 0.003). The mortality rate among patients with delirium was significantly higher than that in the other patient groups (x2 = 12.967, p = 0.024). SLEDAI-2K score was not significantly correlated with mortality (r = 0.123, p = 0.087). Antipsychotics use was associated with mortality (odds ratio 0.053, p = 0.021).ResultsA total of 138 (86.3%) patients met the diagnostic criteria for at least one mental disorder, with the most common being delirium (54.4%). The average Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score significantly differed among the diagnosis groups (p = 0.003). The mortality rate among patients with delirium was significantly higher than that in the other patient groups (x2 = 12.967, p = 0.024). SLEDAI-2K score was not significantly correlated with mortality (r = 0.123, p = 0.087). Antipsychotics use was associated with mortality (odds ratio 0.053, p = 0.021).Antipsychotic use may decrease death risk for patients with NPSLE. Early psychiatric consultation is necessary for patients with SLE who have developed or have suspected psychiatric symptoms in order to establish a comprehensive intervention plan.ConclusionAntipsychotic use may decrease death risk for patients with NPSLE. Early psychiatric consultation is necessary for patients with SLE who have developed or have suspected psychiatric symptoms in order to establish a comprehensive intervention plan. |
---|---|
AbstractList | This study aimed to identify the presence of psychiatric comorbidities as well as investigate the relationship between psychiatric interventions for mental symptoms and mortality in patients with systemic lupus erythematosus (SLE).ObjectiveThis study aimed to identify the presence of psychiatric comorbidities as well as investigate the relationship between psychiatric interventions for mental symptoms and mortality in patients with systemic lupus erythematosus (SLE).We retrospectively evaluated the records of 160 inpatients with SLE who required psychiatric consultation for further therapeutic intervention from 2013 to 2020 in a tertiary general hospital. We collected clinical data, including diagnoses, medications, and mortality rate. We compared clinical characteristics among the diagnosis groups and correlations between variables.MethodWe retrospectively evaluated the records of 160 inpatients with SLE who required psychiatric consultation for further therapeutic intervention from 2013 to 2020 in a tertiary general hospital. We collected clinical data, including diagnoses, medications, and mortality rate. We compared clinical characteristics among the diagnosis groups and correlations between variables.A total of 138 (86.3%) patients met the diagnostic criteria for at least one mental disorder, with the most common being delirium (54.4%). The average Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score significantly differed among the diagnosis groups (p = 0.003). The mortality rate among patients with delirium was significantly higher than that in the other patient groups (x2 = 12.967, p = 0.024). SLEDAI-2K score was not significantly correlated with mortality (r = 0.123, p = 0.087). Antipsychotics use was associated with mortality (odds ratio 0.053, p = 0.021).ResultsA total of 138 (86.3%) patients met the diagnostic criteria for at least one mental disorder, with the most common being delirium (54.4%). The average Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score significantly differed among the diagnosis groups (p = 0.003). The mortality rate among patients with delirium was significantly higher than that in the other patient groups (x2 = 12.967, p = 0.024). SLEDAI-2K score was not significantly correlated with mortality (r = 0.123, p = 0.087). Antipsychotics use was associated with mortality (odds ratio 0.053, p = 0.021).Antipsychotic use may decrease death risk for patients with NPSLE. Early psychiatric consultation is necessary for patients with SLE who have developed or have suspected psychiatric symptoms in order to establish a comprehensive intervention plan.ConclusionAntipsychotic use may decrease death risk for patients with NPSLE. Early psychiatric consultation is necessary for patients with SLE who have developed or have suspected psychiatric symptoms in order to establish a comprehensive intervention plan. ObjectiveThis study aimed to identify the presence of psychiatric comorbidities as well as investigate the relationship between psychiatric interventions for mental symptoms and mortality in patients with systemic lupus erythematosus (SLE).MethodWe retrospectively evaluated the records of 160 inpatients with SLE who required psychiatric consultation for further therapeutic intervention from 2013 to 2020 in a tertiary general hospital. We collected clinical data, including diagnoses, medications, and mortality rate. We compared clinical characteristics among the diagnosis groups and correlations between variables.ResultsA total of 138 (86.3%) patients met the diagnostic criteria for at least one mental disorder, with the most common being delirium (54.4%). The average Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score significantly differed among the diagnosis groups (p = 0.003). The mortality rate among patients with delirium was significantly higher than that in the other patient groups (x2 = 12.967, p = 0.024). SLEDAI-2K score was not significantly correlated with mortality (r = 0.123, p = 0.087). Antipsychotics use was associated with mortality (odds ratio 0.053, p = 0.021).ConclusionAntipsychotic use may decrease death risk for patients with NPSLE. Early psychiatric consultation is necessary for patients with SLE who have developed or have suspected psychiatric symptoms in order to establish a comprehensive intervention plan. |
Author | Hong, Xia Geng, Wenqi Zhang, Shangzhu Zhu, Boheng Wei, Jing Duan, Yanping Cao, Jinya |
AuthorAffiliation | 1 Department of Psychological Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital , Beijing , China 2 Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing , China |
AuthorAffiliation_xml | – name: 2 Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education , Beijing , China – name: 1 Department of Psychological Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital , Beijing , China |
Author_xml | – sequence: 1 givenname: Wenqi surname: Geng fullname: Geng, Wenqi – sequence: 2 givenname: Shangzhu surname: Zhang fullname: Zhang, Shangzhu – sequence: 3 givenname: Jinya surname: Cao fullname: Cao, Jinya – sequence: 4 givenname: Boheng surname: Zhu fullname: Zhu, Boheng – sequence: 5 givenname: Yanping surname: Duan fullname: Duan, Yanping – sequence: 6 givenname: Xia surname: Hong fullname: Hong, Xia – sequence: 7 givenname: Jing surname: Wei fullname: Wei, Jing |
BookMark | eNp9kstuHCEQRVuRI8Vx_ANZscxmJtA8pskmsqw8LFnKJlkjhi48WN3QoWhH_Sf53DAPWXYWZgMq6p4qXd23zVlMEZrmPaNrzjv90U-4lHVLW75mrNNa0FfNOVNKrKgS9OzJ-01ziXhP6-FacyXPm79XsYSqd7tUgkOSoZ8dIBlTLnYIZSEhksmWALEg-RPKjkSYczpIgi05OIILFhjrY5inGQnkpexgtCXhjJ-IrcySE07gSngAgmXuF5I8eYpwKeI8lDonReIsAr5rXns7IFye7ovm19cvP6-_r25_fLu5vrpdOSFUWUmpXN-D092WWye3PeN620vd6tZJsFYKaJVgSnje-lb6DVeuVn0nZbehmvGL5ubI7ZO9N1MOo82LSTaYQyHlO2NztWYAwyuTbZhnG9UK0dGOM-W1o-CFdL3aVNbnI2uatyP0rnqW7fAM-vwnhp25Sw-GUVGJXFbChxMhp98zYDFjQAfDYCOkGU3bSbbfu1O1tT22umouZvCPcxg1-1yYQy7MPhfmlIsq6v4TuXB0ve4Thpek_wAtQsfN |
CitedBy_id | crossref_primary_10_1177_2050313X241229010 crossref_primary_10_5498_wjp_v15_i2_102259 |
Cites_doi | 10.1177/09612033211031008 10.1155/2021/1349042 10.1093/rheumatology/ken260 10.1007/s40265-015-0534-3 10.1016/j.psym.2018.06.007 10.1002/art.40930 10.3899/jrheum.120545 10.1177/0961203318772021 10.1136/annrheumdis-2019-216150 10.1002/art.1780400928 10.1177/0961203320908932 10.1002/art.40764 10.1007/s00296-019-04423-4 10.1016/S0140-6736(19)30546-X 10.1176/appi.neuropsych.13110342 10.1038/s41584-018-0156-8 10.1371/journal.pone.0009302 10.1016/j.jaut.2016.06.013 10.1038/nrrheum.2014.15 10.1136/ard.2010.130476 10.1016/S0140-6736(19)30237-5 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F 10.1177/09612033221127898 10.1136/annrheumdis-2019-215089 10.1177/09612033211045050 10.1007/s10067-018-4259-z 10.1038/nrrheum.2010.62 10.1176/appi.ajp.2013.13040458 |
ContentType | Journal Article |
Copyright | Copyright © 2023 Geng, Zhang, Cao, Zhu, Duan, Hong and Wei. Copyright © 2023 Geng, Zhang, Cao, Zhu, Duan, Hong and Wei. 2023 Geng, Zhang, Cao, Zhu, Duan, Hong and Wei |
Copyright_xml | – notice: Copyright © 2023 Geng, Zhang, Cao, Zhu, Duan, Hong and Wei. – notice: Copyright © 2023 Geng, Zhang, Cao, Zhu, Duan, Hong and Wei. 2023 Geng, Zhang, Cao, Zhu, Duan, Hong and Wei |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fpsyt.2023.1189940 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1664-0640 |
ExternalDocumentID | oai_doaj_org_article_392c171f176244808316f9c0ef45cd67 PMC10424435 10_3389_fpsyt_2023_1189940 |
GrantInformation_xml | – fundername: National High Level Hospital Clinical Research Funding grantid: 2022-PUMCH-B-093 – fundername: Capital Funds for Health Improvement and Research grantid: CFH 2022-2-4012 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ABIVO ACGFO ACGFS ACXDI ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 PGMZT RNS RPM 7X8 5PM |
ID | FETCH-LOGICAL-c446t-556cddec98b3ac5bd139bd59292c5eaa54e264164f32f25f736caa5f855870913 |
IEDL.DBID | M48 |
ISSN | 1664-0640 |
IngestDate | Wed Aug 27 01:31:50 EDT 2025 Thu Aug 21 18:40:43 EDT 2025 Fri Jul 11 04:07:00 EDT 2025 Tue Jul 01 02:53:33 EDT 2025 Thu Apr 24 22:52:25 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c446t-556cddec98b3ac5bd139bd59292c5eaa54e264164f32f25f736caa5f855870913 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Md. Rabiul Islam, University of Asia Pacific, Bangladesh Reviewed by: Zhibo Song, Peking University, China; Carla Marie Cuda, Northwestern University, United States |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fpsyt.2023.1189940 |
PQID | 2851870986 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_392c171f176244808316f9c0ef45cd67 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10424435 proquest_miscellaneous_2851870986 crossref_primary_10_3389_fpsyt_2023_1189940 crossref_citationtrail_10_3389_fpsyt_2023_1189940 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-07-31 |
PublicationDateYYYYMMDD | 2023-07-31 |
PublicationDate_xml | – month: 07 year: 2023 text: 2023-07-31 day: 31 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in psychiatry |
PublicationYear | 2023 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Giani (ref1) 2021; 30 Dörner (ref21) 2019; 393 Govoni (ref6) 2016; 74 Mendelsohn (ref3) 2021; 30 Boeke (ref18) 2018; 59 Schwartz (ref20) 2019; 15 Magro-Checa (ref26) 2016; 76 (ref7) 1999; 42 Bertsias (ref5) 2010; 6 Nikolopoulos (ref13) 2020; 29 Gladman (ref10) 2002; 29 Durcan (ref22) 2019; 393 Ahn (ref2) 2018; 27 Hanly (ref14) 2019; 71 Hanly (ref4) 2020; 79 Fernandez (ref12) 2019; 39 Zirkzee (ref29) 2012; 39 Pego-Reigosa (ref15) 2008; 47 Friedman (ref27) 2014; 171 Wu (ref23) 2019; 38 Bertsias (ref16) 2010; 69 Aringer (ref17) 2019; 71 (ref11) 1992 Lin (ref19) 2015; 27 Pinto (ref25) 2022; 31 Hanly (ref30) 2014; 10 Zhang (ref24) 2021; 2021 Hochberg (ref9) 1997; 40 Fanouriakis (ref8) 2019; 78 Jung (ref28) 2010; 5 |
References_xml | – volume: 30 start-page: 1617 year: 2021 ident: ref3 article-title: Cognitive impairment in systemic lupus erythematosus is negatively related to social role participation and quality of life: a systematic review publication-title: Lupus doi: 10.1177/09612033211031008 – volume: 2021 start-page: 1 year: 2021 ident: ref24 article-title: Clinical features and outcomes of neuropsychiatric systemic lupus erythematosus in China publication-title: J Immunol Res doi: 10.1155/2021/1349042 – volume: 47 start-page: 1498 year: 2008 ident: ref15 article-title: Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/ken260 – volume: 76 start-page: 459 year: 2016 ident: ref26 article-title: Management of Neuropsychiatric Systemic Lupus Erythematosus: current approaches and future perspectives publication-title: Drugs doi: 10.1007/s40265-015-0534-3 – volume: 59 start-page: 523 year: 2018 ident: ref18 article-title: Catatonia associated with systemic lupus erythematosus (SLE): a report of two cases and a review of the literature publication-title: Psychosomatics doi: 10.1016/j.psym.2018.06.007 – volume: 71 start-page: 1400 year: 2019 ident: ref17 article-title: 2019 European league against rheumatism/American College of Rheumatology Classification Criteria for systemic lupus erythematosus publication-title: Arthritis Rheumatol doi: 10.1002/art.40930 – volume: 39 start-page: 2118 year: 2012 ident: ref29 article-title: Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus multidisciplinary approach to diagnosis and therapy publication-title: J Rheumatol doi: 10.3899/jrheum.120545 – volume: 27 start-page: 1338 year: 2018 ident: ref2 article-title: Prevalence, risk factors, and impact on mortality of neuropsychiatric lupus: a prospective, single-center study publication-title: Lupus doi: 10.1177/0961203318772021 – volume: 79 start-page: 356 year: 2020 ident: ref4 article-title: Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approach publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2019-216150 – volume: 29 start-page: 288 year: 2002 ident: ref10 article-title: Systemic lupus erythematosus disease activity index 2000 publication-title: J Rheumatol – volume: 40 start-page: 1725 year: 1997 ident: ref9 article-title: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.1780400928 – volume: 29 start-page: 514 year: 2020 ident: ref13 article-title: Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the 'Attikon' cohort publication-title: Lupus doi: 10.1177/0961203320908932 – volume: 71 start-page: 281 year: 2019 ident: ref14 article-title: Psychosis in systemic lupus erythematosus: results from an international inception cohort study publication-title: Arthritis Rheumatol doi: 10.1002/art.40764 – volume: 39 start-page: 1689 year: 2019 ident: ref12 article-title: Mental disorders in systemic lupus erythematosus: a cohort study publication-title: Rheumatol Int doi: 10.1007/s00296-019-04423-4 – volume: 393 start-page: 2344 year: 2019 ident: ref21 article-title: Novel paradigms in systemic lupus erythematosus publication-title: Lancet doi: 10.1016/S0140-6736(19)30546-X – volume: 27 start-page: e142 year: 2015 ident: ref19 article-title: Negative symptoms in neuropsychiatric systemic lupus erythematosus publication-title: J Neuropsychiatry Clin Neurosci doi: 10.1176/appi.neuropsych.13110342 – volume: 15 start-page: 137 year: 2019 ident: ref20 article-title: Neuropsychiatric lupus: new mechanistic insights and future treatment directions publication-title: Nat Rev Rheumatol doi: 10.1038/s41584-018-0156-8 – volume-title: The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines year: 1992 ident: ref11 – volume: 5 start-page: e9302 year: 2010 ident: ref28 article-title: Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus publication-title: PLoS One doi: 10.1371/journal.pone.0009302 – volume: 74 start-page: 41 year: 2016 ident: ref6 article-title: The diagnosis and clinical management of the neuropsychiatric manifestations of lupus publication-title: J Autoimmun doi: 10.1016/j.jaut.2016.06.013 – volume: 10 start-page: 338 year: 2014 ident: ref30 article-title: Diagnosis and management of neuropsychiatric SLE publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2014.15 – volume: 69 start-page: 2074 year: 2010 ident: ref16 article-title: EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs publication-title: Ann Rheum Dis doi: 10.1136/ard.2010.130476 – volume: 393 start-page: 2332 year: 2019 ident: ref22 article-title: Management strategies and future directions for systemic lupus erythematosus in adults publication-title: Lancet doi: 10.1016/S0140-6736(19)30237-5 – volume: 42 start-page: 599 year: 1999 ident: ref7 article-title: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes publication-title: Arthritis Rheum doi: 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F – volume: 31 start-page: 1563 year: 2022 ident: ref25 article-title: Neuropsychiatric manifestations are associated with increased mortality in Indian patients with lupus: a single center retrospective observational study publication-title: Lupus doi: 10.1177/09612033221127898 – volume: 78 start-page: 736 year: 2019 ident: ref8 article-title: 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2019-215089 – volume: 30 start-page: 1955 year: 2021 ident: ref1 article-title: Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: data from the UK juvenile-onset systemic lupus erythematosus cohort study publication-title: Lupus doi: 10.1177/09612033211045050 – volume: 38 start-page: 107 year: 2019 ident: ref23 article-title: Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort publication-title: Clin Rheumatol doi: 10.1007/s10067-018-4259-z – volume: 6 start-page: 358 year: 2010 ident: ref5 article-title: Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2010.62 – volume: 171 start-page: 151 year: 2014 ident: ref27 article-title: Pharmacological treatments of non-substance-withdrawal delirium: a systematic review of prospective trials publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.2013.13040458 |
SSID | ssj0000399365 |
Score | 2.3358696 |
Snippet | This study aimed to identify the presence of psychiatric comorbidities as well as investigate the relationship between psychiatric interventions for mental... ObjectiveThis study aimed to identify the presence of psychiatric comorbidities as well as investigate the relationship between psychiatric interventions for... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 1189940 |
SubjectTerms | antipsychotics China consultation-liaison psychiatry neuropsychiatric systemic lupus erythematosus Psychiatry referral consultation |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NS-UwFA3iyo0ozuDziwy4G4qmbdLWncqICM5qBHehvU2w8GwfL-3CfzI_d-5N-h7tRjezK_1I096b3HOS3BPGLkVa5ZKYqlRQRGkSQ1TE1XUEAihnJq5FTUMDz7_V40v69CpfJ1t90ZqwIA8cftwVxm8QmbACWy1SCdoYS9kCro1NJdTK55FjzJuQKd8HU9xVMmTJIAsrruzKfdDayTjBXgJJBo12TCKRF-yfocz5GslJ0Hk4YPsjWuS3oZaHbMe0R-zvbds3Y_ZUA46vSX3VOP7ukTSiat60fNRLdZwGWrlXrdwubG6ABwFnPFgOq8Fxs_4I6q2dG9wNL7HMft1tsjC516DlneXTIoCSN5dhJp8DBkP3jb08_Ppz_xiNGyxEgCywjyQaCLs3KPIqKUFWNcLBqpaImGKQpixlahAvIaGySWxjabNEAZ61uZTYzAuRfGe7bdeaY8YtIo3M1qpGQplamRUGSymVERlgQYlZMLH52RpG9XHaBGOpkYWQgbQ3kCYD6dFAC_Zz-8wqaG98evcd2XB7J-lm-xPoTXr0Jv2VNy3Yj40HaGxnNHlStqYbnI4RmtJH52rB8plrzN44v9I2b16xW9AEMwLTk_9Rx1O2R98dBpjP2G6_Hsw5IqO-uvCN4B8PnRGw priority: 102 providerName: Directory of Open Access Journals |
Title | Antipsychotics reduces mortality in patients with neuropsychiatric systemic lupus erythematosus: a retrospective study of psychiatric consultation cases |
URI | https://www.proquest.com/docview/2851870986 https://pubmed.ncbi.nlm.nih.gov/PMC10424435 https://doaj.org/article/392c171f176244808316f9c0ef45cd67 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Na9wwEBUhvfRSGprS7UdQIbfgNrIt2S6EkJaGEEhOXchN2GOpNWztrWVD95_k53ZG1i4xtCW3xWuPkUfSvCdp3jB2LNIql8RUpYIiSpMYoiKuTiMQQDkzcS1qWhq4uVVXy_T6Tt7tsW25o_AB3V-pHdWTWvarD79_bc5xwJ8R48R4-9Gu3YaORcYJTgDIH1Kk8E8wMmVU0eAmwH0_M1M09tUlhVJpRJtYUx7NP8zMYpWX9J_h0Pkpygdh6fI5exbwJL-YOsAB2zPtC3Z_0Q5NyK9qwPGe9FmN4z99MxF386blQVHVcVqK5V7Xcnf0uQE-STzjj9W4Hh03_WbSd-3c6D7xEm0OfbfN0-RepZZ3lj80AZTeuZr2-jlguHSHbHn59duXqyiUYIgAeeIQSXQhToBQ5FVSgqxqBIxVLRFTxSBNWcrUIKJCymWT2MbSZokCvGpzKXEiKETyku23XWteMW4Ri2S2VjVSztTKrDBopVRGZICGErNgYvuxNQR9ciqTsdLIU8hB2jtIk4N0cNCCneyeWU_qHP-9-zP5cHcnKWv7C13_XYeBqhEvgsiEFRglkLpSITZlCzg1NpVQq2zB3m97gMaRSNsrZWu60ekYwSs1OlcLls-6xuyN83_a5ofX9Ba0BY3Q9fUjzL9hT6lZ0wrzW7Y_9KN5h9BoqI78ksKR7_V_APp2E5s |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antipsychotics+reduces+mortality+in+patients+with+neuropsychiatric+systemic+lupus+erythematosus%3A+a+retrospective+study+of+psychiatric+consultation+cases&rft.jtitle=Frontiers+in+psychiatry&rft.au=Geng%2C+Wenqi&rft.au=Zhang%2C+Shangzhu&rft.au=Cao%2C+Jinya&rft.au=Zhu%2C+Boheng&rft.date=2023-07-31&rft.issn=1664-0640&rft.eissn=1664-0640&rft.volume=14&rft.spage=1189940&rft_id=info:doi/10.3389%2Ffpsyt.2023.1189940&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-0640&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-0640&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-0640&client=summon |